Lung Cancer: Targets and Therapy
Volume 15, 2024 - Issue
Open access
116
Views
0
CrossRef citations to date
0
Altmetric
EXPERT OPINION
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
Sai-Hong Ignatius Ou1 University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-1764-4975
Xiuning Le2 University of Texas MD Anderson Cancer Center, Houston, TX, USA
, Misako Nagasaka1 University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA
https://orcid.org/0000-0001-5308-615X
Thanyanan Reungwetwattana3 Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
https://orcid.org/0000-0002-3147-7640
Myung-Ju Ahn4 Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
, Darren WT Lim5 Duke-NUS School of medicine, National Cancer Center Singapore, Republic of Singapore
, Edgardo S Santos6 Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA
https://orcid.org/0000-0003-0776-4903
Elaine Shum7 NYU Langone Perlmutter Cancer Center, NY, NY, USA
, Sally CM Lau7 NYU Langone Perlmutter Cancer Center, NY, NY, USA
, Jii Bum Lee8 Yonsei Cancer Center Yonsei University, Seoul, Republic of Korea
https://orcid.org/0000-0001-5608-3157
Antonio Calles9 Department of Medicine, Division of Medical Oncology, Early Drug Development and Phase I Unit, Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain
, Fengying Wu10 Shanghai Chest hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China
, Gilberto Lopes11 Department of Medicine, Division of Medical Oncology, Sylvester Comprehensive Cancer Center at the University of Miami and the Miller School of Medicine, Miami, FL, 33136, USA
, Virote Sriuranpong12 Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
https://orcid.org/0000-0002-7847-894X
Junko Tanizaki13 Department of Medicine, Kindai University School of Medicine, Osaka, Japan
, Hidehito Horinouchi14 Department of Thoracic Oncology, National Cancer Center Hospital Tokyo, Tokyo, Japan
, Marina C Garassino15 Department of Medicine, Division of Medical Oncology-Hematology, University of Chicago Medicine, Chicago, IL, USA
, Sanjay Popat16 Royal Marsden Hospital, London, Imperial College, London, UK
, Benjamin Besse17 Gustave Roussy Cancer Campus, Villejuif, France; Paris-Saclay University, Orsay, France
, Rafael Rosell18 Department of Hematology-Oncology, National University Cancer Institute, National University Hospital Singapore, Republic of Singapore
https://orcid.org/0000-0003-0817-3400
Ross A Soo19 IOR, Quirón-Dexeus University Institute; ICO, Catalan Institute of Oncology; IGTP, Germans Trias i Pujol Research Institute, Barcelona, Spain
show all
Pages 87-114
|
Received 15 Mar 2024, Accepted 27 May 2024, Published online: 21 Jun 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.